How will India’s leading drugmaker handle legal setbacks, volatile market trends, and competition in generics and specialty products?

Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

The company’s revenue from operations saw a significant decline of 39%, dropping to ₹12.9 Crore from ₹21.2 Crore in the ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.31% to 1,803.25 Indian rupees Tuesday, on what proved to be ...